Complement activation is a well-known immunosurveillance mechanism against cancer, the three pathways, although having a different initiating event, end up with a convertase complex that cleaves the C3 complement into C3a and C3b, further contributing to the formation of the Membrane Attack Complex (MAC). This evidence concerns the gene C3 and cancer.